Vivos Therapeutics (VVOS) Net Cash Flow (2020 - 2026)
Vivos Therapeutics (VVOS) reported Net Cash Flow of $81000.0 for Q1 2026, up 102.07% year-over-year from $40085.6 in Q1 2025, and up 108.03% quarter-over-quarter from -$1.0 million in Q4 2025.
Vivos Therapeutics (VVOS) Net Cash Flow (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Net Cash Flow data on file, last reported at $81000.0 in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $81000.0, up 102.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.7 million (down 4246.47% YoY), and the FY2025 annual result was -$4.2 million, down 191.64% from the prior year.
- Net Cash Flow climbed to $81000.0 in Q1 2026 per VVOS's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $4.3 million in Q2 2024 and troughed at -$9.4 million in Q2 2025.
- A 5-year average of -$2.0 million and a median of -$1.4 million in 2025 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow soared 236.47% in 2024, then plunged 1878.43% in 2025.
- A 5-year view of Net Cash Flow shows it stood at -$3.2 million in 2022, then jumped by 122.06% to $703000.0 in 2023, then plunged by 107.25% to -$51000.0 in 2024, then sank by 1878.43% to -$1.0 million in 2025, then jumped by 108.03% to $81000.0 in 2026.
- Business Quant data shows VVOS's Net Cash Flow at $81000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81,000.00 |
| Mar 31, 2026 | 81,000.00 |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -51,000.00 |
| Dec 31, 2024 | -51,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Jun 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 968,000.00 |
| Mar 31, 2024 | 968,000.00 |
| Dec 31, 2023 | 703,000.00 |
| Dec 31, 2023 | 703,000.00 |